Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideDGXQuest Diagnostics
FinDog View：Bullish
TMOThermo Fisher Scientific
FinDog View：Neutral
| Metric | DGX | TMO |
|---|
| Close | 251.82 | 697.00 |
| Market Cap | $27.7B | $258B |
| 1M | +8.04% | +3.25% |
| P/E (TTM) | 24.5 | 36.4 |
| Forward P/E | 19.9 | 24.6 |
| P/E 5-Yr Percentile | 91 | 78 |
| P/S | 2.3 | 5.4 |
| P/B | 3.6 | 4.7 |
| Dividend Yield | 2.10% | 0.29% |
| Latest Quarter Revenue | $3.1B | $12.1B |
| Revenue YoY | +10.0% | +9.1% |
| Gross Margin | 33.6% | — |
| Latest Quarter EPS | 2.78 | 4.64 |
| Avg Post-Earnings Move | ±1.7% | ±1.2% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 2.95% | 1.82% |
| 90-Day Net Insider Buying | −$8.2M | −$40.3M |
DGX · Revenue, Last 8 Quarters ($B)
TMO · Revenue, Last 8 Quarters ($B)
